Temporal Dynamics of Cardiovascular Risk in Patients with Chronic Obstructive Pulmonary Disease During Stable Disease and Exacerbations: Review of the Mechanisms and Implications

Autor: Simons SO, Heptinstall AB, Marjenberg Z, Marshall J, Mullerova H, Rogliani P, Nordon C, Hawkins NM

Publikováno v: International Journal of COPD, Vol Volume 19, Pp 2259-2271 (2024)

Sami O Simons,1,2 Amy B Heptinstall,3 Zoe Marjenberg,3 Jonathan Marshall,4 Hana Mullerova,4 Paola Rogliani,5 Clementine Nordon,4 Nathaniel M Hawkins6 1Department of Respiratory Medicine, NUTRIM Institute for Nutrition and Translational Research in Me

Externí odkaz: https://doaj.org/article/480d1f8cbd7c44a58ecd99d23810e139

History of Respiratory Events Prior to a First COPD Diagnosis and Future Exacerbations: A Longitudinal Observational Cohort Database Study in Japan

Autor: Ding B, Zaha R, Makita N, Graham S, Lambrelli D, Huse S, Müllerová H, Nordon C, Muro S

Publikováno v: International Journal of COPD, Vol Volume 18, Pp 247-258 (2023)

Bo Ding,1 Rebecca Zaha,2 Naoyuki Makita,3 Sophie Graham,4,5 Dimitra Lambrelli,4 Samuel Huse,6 Hana Müllerová,7 Clementine Nordon,7 Shigeo Muro8 1BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden; 2Formerly of Data Analytics, Evidera, Beth

Externí odkaz: https://doaj.org/article/d8fbf75998604e11afc704a6ad8d9d77

The use of random-effects models to identify health care center-related characteristics modifying the effect of antipsychotic drugs

Autor: Nordon C, Battin C, Verdoux H, Haro JM, Belger M, Abenhaim L, van Staa TP

Publikováno v: Clinical Epidemiology, Vol Volume 9, Pp 689-698 (2017)

Clementine Nordon,1 Constance Battin,1 Helene Verdoux,2 Josef Maria Haro,3 Mark Belger,4 Lucien Abenhaim,1 Tjeerd Pieter van Staa5 On behalf of the IMI GetReal WP2 Group 1Epidemiological Research, Analytica LASER, Paris, 2Population Health Research C

Externí odkaz: https://doaj.org/article/2066d10e6a2a4b1e99d8d6a5ddac6f01

A first step towards best practice recommendations for the design and statistical analyses of pragmatic clinical trials: A modified Delphi approach

Autor: Palin, V., Staa, T.P. van, Steels, S., Troxel, A.B., Groenwold, R.H.H., MacDonald, T.M., Torgerson, D., Faries, D., Mancini, P., Ouwens, M., Frith, L.J., Tsirtsonis, K., MacLennan, G., Nordon, C., GetReal Initiative

Publikováno v: British Journal of Clinical Pharmacology, 88(12), 5183-5201. WILEY
Palin, V, Van Staa, T, Steels, S, Troxel, A, Groenwold, R, MacDonald, T, Torgerson, D, Faries, D, Mancini, P, Ouwens, M, Frith, L, Tsirtsonis, K, MacLennan, G & Nordon, C 2022, ' A first step towards best practice recommendations for the design and statistical analyses of pragmatic clinical trials: A modified Delphi approach ', Proceedings of the British Pharmacological Society . https://doi.org/10.1111/bcp.15441

AimPragmatic clinical trials (PCTs) are randomized trials implemented through routine clinical practice, where design parameters of traditional randomized controlled trials are modified to increase generalizability. However, this may introduce statis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bd0da513d04d8e6b5b22ab7421cd350
http://hdl.handle.net/1887/3572044

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.